The update included background on the relationship between GLP-1 receptor agonists and endoscopic procedures, followed by clinical strategies for patients taking these medications.
The recent guidance from AGA includes 12 best practices that address dietary options, enteral and parenteral nutrition, patient monitoring, and the need for multidisciplinary care.
Popular new glucagon-like peptide 1 receptor agonists require some preprocedural considerations but not necessarily discontinuation of the drugs to support the success of endoscopic procedures.